Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cells
Arailym Sarsembayeva, Melanie Kienzl, Eva Gruden, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 22

Showing 22 citing articles:

A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer
Pengyu Yao, Liang Su, Zhenying Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
MariaLuisa Vigano, Lixing Wang, Alia As’sadiq, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Evaluation of regulatory T-cells in cancer immunotherapy: therapeutic relevance of immune checkpoint inhibition
Ranjeet Singh, Prateek Srivastava, Partha Pratim Manna
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 6
GPR55 in the tumor microenvironment of pancreatic cancer controls tumorigenesis
Dušica Ristić, Thomas Bärnthaler, Eva Gruden, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Cannabinoid receptor 2 selective agonist ameliorates adjuvant-induced arthritis by modulating the balance between Treg and Th17 cells
Na Tian, Cui Yang, Yu Du, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies – Current status of preclinical and clinical research
Robert Ramer, Burkhard Hinz
Pharmacology & Therapeutics (2025), pp. 108851-108851
Closed Access
Eight Weeks of Daily Cannabidiol Supplementation Improves Sleep Quality and Immune Cell Cytotoxicity
Jacob N. Kisiolek, Victoria Flores, Arjun Ramani, et al.
Nutrients (2023) Vol. 15, Iss. 19, pp. 4173-4173
Open Access | Times Cited: 11
Comparative Study of the Immune Microenvironment in Heterotopic Tumor Models
Melanie Kienzl, Kathrin Maitz, Arailym Sarsembayeva, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 295-295
Open Access | Times Cited: 4
Enhanced CT-based radiomics model to predict natural killer cell infiltration and clinical prognosis in non-small cell lung cancer
Xiangzhi Meng, Haijun Xu, Yicheng Liang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine
Magdalena Skórzewska, Katarzyna Gęca
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1334-1348
Open Access | Times Cited: 3
Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?
Arailym Sarsembayeva, Rudolf Schicho
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Molecular Targets for Cannabinoids in Natural Killer Cells: Do They Modulate the Antitumor Activity?
Miguel Olivas-Aguirre, Cecilia Gutiérrez-Iñiguez, Igor Pottosin, et al.
Receptors (2024) Vol. 3, Iss. 2, pp. 122-144
Open Access | Times Cited: 2
Enhanced oral bioavailability and in vitro evaluation of cannabidiol camel milk-derived exosome formulation in resistant MDA-MB-231 and MDA-MB-468 breast cancer cells
Mounika Aare, Arvind Bagde, Aakash Nathani, et al.
International Journal of Pharmaceutics (2024) Vol. 663, pp. 124375-124375
Closed Access | Times Cited: 2
Altered Treg Infiltration after Discoidin Domain Receptor 1 (DDR1) Inhibition and Knockout Promotes Tumor Growth in Lung Adenocarcinoma
Kathrin Maitz, Paulina Valadez-Cosmes, Sofia Raftopoulou, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5767-5767
Open Access | Times Cited: 5
Construction of an anoikis-associated lncRNA-miRNA-mRNA network reveals the prognostic role of β-elemene in non-small cell lung cancer
Kai Tan, Changhui Zhang, Zuomei He, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Mononuclear cell composition and activation in blood and mucosal tissue of eosinophilic esophagitis
Eva Gruden, Melanie Kienzl, Dušica Ristić, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Endocannabinoid Receptor 2 Function is Associated with Tumor-Associated Macrophage Accumulation and Increases in T Cell Number to Initiate a Potent Antitumor Response in a Syngeneic Murine Model of Glioblastoma
Jin Duan, Jieling Chen, Yilin Lin, et al.
Cannabis and Cannabinoid Research (2024)
Closed Access | Times Cited: 1
GPCRs: emerging targets for novel T cell immune checkpoint therapy
Kaitlyn Dickinson, Elliott J. Yee, Isaac Vigil, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 12
Open Access | Times Cited: 1
GPR116 receptor regulates the antitumor function of NK cells via Gαq/HIF1α/NF-κB signaling pathway as a potential immune checkpoint
Dandan Guo, Chenxu Jin, Yaoxin Gao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Treatment of malignant diseases with phytocannabinoids: promising observations in animal models and patients
Gerhard Nahler
Exploration of Medicine (2023), pp. 847-877
Open Access | Times Cited: 2
Exploring the Interplay Between Cannabinoids and Thymic Functions
Marvin Paulo Lins, Igor Santana de Melo
Toxicological Sciences (2024)
Closed Access
Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles
Eva Gruden, Melanie Kienzl, Carina Hasenoehrl, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2023) Vol. 196, pp. 102585-102585
Closed Access | Times Cited: 1
Page 1

Scroll to top